Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.
about
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic reviewCan quality of life assessments differentiate heterogeneous cancer patients?Associations of adipose and muscle tissue parameters at colorectal cancer diagnosis with long-term health-related quality of life.Clinical relevance of quality-of-life data in laryngectomized patients.Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib.Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis.Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study.Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapyThe impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapyA complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.Mindfulness for the self-management of fatigue, anxiety, and depression in women with metastatic breast cancer: a mixed methods feasibility studyFatigue as a Driver of Overall Quality of Life in Cancer Patients.Physical Exercise Training versus Relaxation in Allogeneic stem cell transplantation (PETRA Study) - Rationale and design of a randomized trial to evaluate a yearlong exercise intervention on overall survival and side-effects after allogeneic stem cInterpreting small treatment differences from quality of life data in cancer trials: an alternative measure of treatment benefit and effect size for the EORTC-QLQ-C30.Enhanced involvement of general practitioners in cancer rehabilitation: a randomised controlled trial.The Patient Remote Intervention and Symptom Management System (PRISMS) - a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised conHealth-related quality of life and psychological distress among cancer survivors in Southeast Asia: results from a longitudinal study in eight low- and middle-income countriesA randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility study.Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trialCorrelates of physical activity among colorectal cancer survivors: results from the longitudinal population-based profiles registry.A randomised controlled trial of hospital-based case management to improve colorectal cancer patients' health-related quality of life and evaluations of careValidation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancerThe role of personality in the course of health-related quality of life and disease-specific health status among colorectal cancer survivors: A prospective population-based study from the PROFILES registryStandard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial.Modeling how substitution of sedentary behavior with standing or physical activity is associated with health-related quality of life in colorectal cancer survivorsA high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.Using patient-reported outcome measures for improved decision-making in patients with gastrointestinal cancer - the last clinical frontier in surgical oncology?Associations of sedentary time and patterns of sedentary time accumulation with health-related quality of life in colorectal cancer survivors.Associations of objectively measured moderate-to-vigorous physical activity and sedentary behavior with quality of life and psychological well-being in prostate cancer survivorsA planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901.Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidityThe impact of esophageal reflux-induced symptoms on quality of life after gastrectomy in patients with gastric cancer.A point of minimal important difference (MID): a critique of terminology and methods.Persisting fatigue in Hodgkin lymphoma survivors: a systematic review.Effects of systematic rehabilitation programs on quality of life in patients undergoing lung resection.Lymphoma InterVEntion (LIVE) - patient-reported outcome feedback and a web-based self-management intervention for patients with lymphoma: study protocol for a randomised controlled trial.Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.Clinically distinct trajectories of fatigue and their longitudinal relationship with the disturbance of personal goals following a cancer diagnosis.Adolescent and young adult (AYA) lymphoma survivors report lower health-related quality of life compared to a normative population: results from the PROFILES registry.
P2860
Q26824003-634AF7FA-244C-4E8E-895A-F86A328C2CDBQ33740600-83436B71-464C-4D5D-BB61-DBA46CA2B6A7Q33841708-8074DB39-5BE4-4D0D-8B10-E4D9173249C6Q34213267-673F3806-E734-428A-9598-AECE85B21723Q34439059-A7301D1D-5909-4251-8E86-5B7E20AB1E17Q34469769-C54C0499-A797-464C-9619-C31C24067D9FQ34626404-422AB54F-2B46-40E6-9F3C-58849622FAD2Q34640489-8852862C-9B4E-4618-A22F-971B76E9A520Q34640628-07AD61B6-DF34-4D0B-BC8E-8AE8D50BF012Q35098307-419563C8-8E34-4ABE-8676-9A492F9C6154Q35110167-0FA08C8F-9615-46E8-92C3-DE0622EFB123Q35330774-A1EDFBBF-E05A-4B2D-8F82-042EB13234E6Q35662352-97D3AF41-80C2-49EB-9C0F-25CDB566ACABQ35765750-66FBB301-6DDD-4CB0-9FB9-62B198D9AFE9Q35843061-A9EBE818-1AE2-49A8-9F6E-6D37CC3FF468Q35904182-24D74B9A-FCD7-475E-9695-0AE187A366D1Q36197971-B54D29B3-3052-41D0-9F50-39197D939733Q36248091-58EC319B-5B65-4E62-A842-4ED59EA63DE9Q36304063-6A879B11-BBD5-45C1-BE8E-30246FD5B8D2Q36322815-EF812CD1-57F2-419C-9972-213725D6BE59Q36400332-EA08D0D7-DF9E-4BAB-96E6-C50CB3B1B0ACQ36496135-F6BCD9A7-96E7-4221-9154-C7EFD8FB138AQ36521203-FDB583D6-0809-42BC-AD82-04B1E5D2A3CAQ36551034-6107AF9F-C94B-4114-84B6-80778521499DQ36680034-1166880E-9A9D-45F5-8E75-77E1642E363DQ36698997-14DE600E-16B2-4F7F-A1A9-6FEC5C592C28Q36862345-DF24E597-CA10-4C26-A860-FCB30D6D7BF9Q36927798-514919AA-D096-4A9C-AA67-A6348174F7B5Q37085334-65CC7148-7D68-4E53-8AE5-E4119650C622Q37171890-3F525B79-DC27-488C-BC79-B7FEBD0CFF2CQ37542432-3D9ECB92-CFB1-48C1-93C8-9A751D0693ADQ37594343-A1079E37-EACB-4DE1-8085-8477B5CB6C72Q37717702-2FE3F476-6FD1-4826-96C3-46BCE125E63FQ37863111-CD126E9C-5CCC-4758-820E-A86D01C643B8Q38111234-013F2EE1-4195-441D-9B44-77C1AC262F77Q38292244-7FB349EB-8F50-47D3-8E44-ACD0DD932C2AQ38377380-7EBC7BBA-FB13-47BB-9A8A-F409A823F154Q38459634-D4EA1181-3DEF-4E01-9DAA-F9C6227B49DCQ38716124-E83032F0-AEBE-4B72-9D66-0DBE723FCBDFQ38771779-236F0E88-1C50-4605-B826-E3FB809021A0
P2860
Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@en
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@en-gb
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@nl
type
label
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@en
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@en-gb
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@nl
prefLabel
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@en
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@en-gb
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@nl
P50
P356
P1476
Evidence-based guidelines for ...... of Life Questionnaire Core 30.
@en
P2093
Madeleine T King
Marrissa Martyn St-James
P356
10.1200/JCO.2010.28.0107
P407
P577
2010-11-22T00:00:00Z